| |
|
|
| Year : 2009 | Volume
: 20
| Issue : 2 | Page : 278-281 |
|
| Conns' syndrome - atypical presentations |
|
|
KVS Hari Kumar1, Sangeeta Jha2, Ratan Jha3, KD Modi1
1 Departments of Endocrinology, Medwin Hospitals, Chirag Ali Lane, Nampally, Hyderabad, India
2 Departments of Surgical Endocrinology, Medwin Hospitals, Chirag Ali Lane, Nampally, Hyderabad, India
3 Departments of Nephrology, Medwin Hospitals, Chirag Ali Lane, Nampally, Hyderabad, India
Click here for correspondence address and email
|
|
 |
|
 Abstract | | |
Primary hyperaldosteronism (Conns' syndrome) commonly presents with a combination of clinical features of hypokalemia and hypertension. Atypical presentations like normotension, normokalemia and neurological ailments are described in few cases. We encountered two such cases, the first presenting with acute neurological complaint and second case having insignificant hypertension. Both the patients had a characteristic biochemical and imaging profile consistent with primary hyperaldosteronism and responded to surgical resection of adrenal adenoma. Keywords: Paralysis, Hyperaldosteronism, Adrenal adenoma
How to cite this article:
Hari Kumar K, Jha S, Jha R, Modi K D. Conns' syndrome - atypical presentations. Saudi J Kidney Dis Transpl 2009;20:278-81 |
| Introduction | |  |
Primary hyperaldosteronism is the commonest form of endocrine hypertension and is now considered as most common cause of secondary hypertension. [1] It usually presents with symptoms of hypokalemia like muscle weakness, cramps, tetany and severe or resistant arterial hypertension. However, there is a wide spectrum of clinical and biochemical variations in primary hyperaldosteronism. In particular, hypokalemia is not evident in 7 to 38% of cases and normotensive primary hyperaldosteronism is rare. [2],[3] Other than these variations, primary hyperaldosteronism presents occasionally in emergency room with a catastrophic complaint posing a diagnostic dilemma. [4] We report these 2 cases for their unusual features like metabolic myopathy and intermittent hypertension in primary hyperaldosteronism.
| Case Reports | | |
Case 1
45 yrs old male, a known case of hypertension for 5 years and Diabetes mellitus for 2 yrs on antihypertensives (including diuretics) and oral hypoglycemic agents presented to emergency department with history of paraparesis of acute onset without associated bladder involvement or weakness of other groups of muscles. Patient gave history of episodic proximal muscle weakness of lower limbs over past one year duration often requiring support. He also complained of polyuria and nocturia over past 2 years. Initial examination revealed BP-160/100, absent pedal edema and Grade II power in both lower limbs with no sensory loss. Fundus examination revealed Grade II hypertensive retinopathy changes. Other neurological and systemic examination was normal. There were no features of Cushings syndrome.
Investigations revealed normal hematological and renal parameters. Serum potassium was 1.8 meq/L and Arterial blood gas analysis showed pH of 7.44 and HCO3 of 26 meq/L, Urine potassium excretion was 220 meq/L with a volume of 6.9 liters. Calculation of TTKG revealed significant potassium loss of renal origin. ECG showed changes of LVH and hypokalemia. CXR and USG abdomen were normal. Low doses dexamethasone suppressed the morning cortisol. In view of significant hypokalemia with kaliuresis and hypertension, aldosteronism was suspected and investigated. Plasma renin activity was 0.4 ng/mL.hr (1.4-2.6) and post saline plasma aldosterone was 62 ng/dL (not suppressible). CT scan abdomen revealed a minimally enhancing isodense mass of 1.2 × 1.2 cms involving medial limb of left adrenal gland.
He was treated initially with potassium supplements and spironolactone 100 mg twice a day for 4 weeks resulting in good BP control. He underwent left adrenalectomy and intraoperative period was uneventful. On gross examination the tumor was well circumscribed and histopathological examination revealed features of both zona reticularis and glomerulata in the tumor. Post operatively patient had complete recovery of weakness and was not requiring any antihypertensive drugs. Serum potassium on follow up was normal.
Case 2
33 year old lady presented with recurrent episodic muscle weakness of 4 years duration associated with myalgia and backache. Patient gave history of a hypertensive record on a couple of occasions during past 2 years but was not prescribed with antihypertensives and advised follow up. She gave no symptoms to suggest previous history thyroid illness, connective tissue disease and similar complaints in family members. She had regular menstrual cycles and her only son is 4 years old. Clinical examination revealed normotensive lady with no edema or palpable abdominal mass. Neurological examination revealed Grade IV power in all groups of muscles with normal deep tendon jerks. BP monitoring in hospital ranged between a maximum of 150/90 mmHg and a minimum of 110/80 mmHg without any antihypertensive drugs. Serum sodium, potassium and chloride were 141, 1.9, and 102 meq/L respectively. Arterial blood gas analysis showed metabolic alkalosis with pH - 7.493 and HCO3 - 28.1 mmol/L. Thyroid function tests were normal. ECG showed presence of U waves and there were no hypertensive changes. Spot urine potassium showed 46 meq/L and because of hypokalemia with kaliuresis she was investigated for primary hyperaldosteronism. Ultrasonography of the abdomen revealed 3.6 × 2.7 cm round, hypoechoic lesion in right adrenal gland. CT scan abdomen confirmed the right adrenal adenoma of 3.2 × 2.5 cms in size with non homogenous enhancement. Plasma Renin Activity was 0.04 ng/mL.hr and plasma aldosterone was 51.6 ng/dL. Overnight dexamethasone test revealed suppressible cortisol levels. Diagnosis of Conns' syndrome was established by:
- presentation with episodic weakness
- Hypokalemia
- increased plasma aldosterone and low plasma renin activity and
- adrenal adenoma on imaging
The patient was managed with potassium replacement initially followed by Spironolactone in a daily dose of 200 mg for 4 weeks preoperatively, which improved her weakness and hypokalemia. She underwent right adrenalectomy and intraoperative period was uneventful. On gross examination the tumor was well circumscribed and histopathological examination confirmed the typical features of adrenal adenoma. Post operatively patient had no features of weakness and her serum potassium normalized without any drugs.
| Discussion | | |
Primary aldosteronism is a common, often undiagnosed cause of hypertension requiring a high index of suspicion in identification. Normokalemic variant is described in majority of patients but acute neurological ailment as presenting feature is an extremely rare association. [5] Severe hypokalemia goes unnoticed in otherwise healthy persons but can often present with severe manifestations in some patients. Paralytic myopathy in association with hypokalemia is a recognized feature of Conns' syndrome and is seen more commonly in Asian patients. [6] The possible provocative factors are high carbohydrate intake, heavy exercise. The severity of hypokalemia is related to dietary sodium intake and our patient had severe hypokalemia despite a low sodium diet. This increased prevalence of hypokalemic paralysis in Oriental subjects appears to be related to dietary habits rather than underlying genetical difference. Thus, spontaneous hypokalemia or diuretic induced hypokalemia associated with hypertension is a strong indicator of underlying hyperaldosteronism and should be evaluated.
The classical recommendation in patients with significant hypertension requiring 2 or more drugs with poor control, young hypertensives and hypertension associated with hypokalemia is to investigate for the presence of primary hyperaldosteronism. Our second patient recorded mild hypertension intermittently and was not treated with antihypertensives throughout her illness. Primary hyperaldosteronism is now increasingly being seen as the underlying cause in patients with hitherto diagnosis of essential hypertension. [7] The likelihood of demonstration of primary hyperaldosteronism appears directly related to the severity of hypertension with increased incidence in patients with more severe hypertension and less common (< 2%) with mild hypertension. The arterial hypertension of primary hyperaldosteronism is usually explained by an initial increase in sodium reabsorption related to the effect of aldosterone on distal renal tubules. Blood pressure remains high because of increased peripheral vascular resistance, a direct hypertensive effect of aldosterone on the central nervous system, and increased vascular sensitivity to vasopressors such as angiotensin and adrenalin.
The occurrence of normotension in primary hyperaldosteronism is exceedingly rare and mostly described in Eurasians (especially Japanese). The patients are mostly middle-aged females and the diagnosis is usually raised by signs of hypokalemia (fatigue, paresthesia, tetany). The mechanisms proposed for normal blood pressure are early diagnosis, absence of volemic expansion or a low salt diet and vasodilator production. [3] Postoperative ambulatory BP monitoring after removal of the adrenal adenoma revealed that these patients had a marked fall in blood pressure. Therefore, the normal blood pressure corresponds to relative hypertension in subjects with low spontaneous blood pressure.
In conclusion, primary hyperaldosteronism with its varied clinical characteristics presents a diagnostic dilemma to the clinicians. Earlier approach of hypertension with hypokalemia to suspect this condition may be missing many borderline hypertensive or normotensive cases. Atypical presentations are increasingly being described in literature and screening for this condition should be undertaken in all cases of hypertension with spontaneous or secondary hypokalemia and in patients with hypokalemic paralysis without hypertension.
| References | | |
| 1. | Young WF. Primary aldosteronism-renaissance of a syndrome: Review. Clin Endocr 2007;66:607-18.  [PUBMED] [FULLTEXT] |
| 2. | Bernini G, Moretti A, Argenio G, Salvetti A. Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur J Endocrinol 2002;146(4):523-9. |
| 3. | Vantyghem MC, Ronci N, Provost F, et al. Aldosterone-producing adenoma without hypertension: A report of two cases. Eur J Endocrinol 1999;141:279-85. [PUBMED] [FULLTEXT] |
| 4. | Karagiannis A, Tziomalos K, Kakafika A, Harsoulis F, Zamboulis C. Paralysis as first manifestation of primary Aldosteronism. Nephrol Dial Transplant 2004;19:2418-24. [PUBMED] [FULLTEXT] |
| 5. | Mourad JJ, Milliez P, Blacher J, Safar M, Girerd X. Conn adenoma manifesting as reversible tetraparesis and rhabdomyolysis. Rev Med Interne 1998;19:203-5. [PUBMED] [FULLTEXT] |
| 6. | Huang YY, Hsu BR, Tsai JS. Paralytic myopathy: A leading clinical presentation for primary aldosteronism in Taiwan. J Clin Endocrinol Metab 1996;81:4038-41. [PUBMED] [FULLTEXT] |
| 7. | Calhoun DA. Aldosteronism and hypertension: Mini review. Clin J Am Soc Nephrol 2006; 1:1039-45. [PUBMED] [FULLTEXT] |
Correspondence Address:
KVS Hari Kumar
Department of Endocrinology, Medwin Hospitals, Nampally, Hyderabad
India
  | Check |
PMID: 19237819 
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 7881 | | | Printed | 120 | | | Emailed | 0 | | | PDF Downloaded | 746 | | | Comments | [Add] | | |
|
|
